Keyphrases
Cell-based
100%
Assay Conditions
75%
Ebola Virus
50%
EC50
50%
Drug Screen
50%
Virus
25%
Age of Infection
25%
FDA-approved Drugs
25%
Drug Potency
25%
Primary Cells
25%
Established Cell Lines
25%
Citrate
25%
In Vitro Data
25%
Effective Concentration
25%
Multiplex Assay
25%
Inhibition Rate
25%
Standard Operating Procedures
25%
Virus Activity
25%
Cell Passage number
25%
Input Time
25%
Ebola Virus Disease
25%
Toremifene
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiviral Drug
100%
Ebola Virus
100%
EC50
100%
Infection
50%
Ebola Virus Disease
50%
Toremifene
50%
Diseases
50%
Medicine and Dentistry
Ebolavirus
100%
Antiviral Drug
66%
In Vitro
33%
Infection
33%
Virus Infection
33%
Cell Line
33%
Drug Potency
33%
Toremifene
33%
Diseases
33%
Virus
33%